Lawrence Frank is a founder of the firm and comes to the firm after gaining over eleven years of patent law experience at Kenyon & Kenyon LLP, a premier New York intellectual property law firm.
Dr. Frank’s patent practice encompasses patent drafting, prosecution, opinion (freedom-to-operate, invalidity and non-infringement, including with respect to Orange Book-listed patents), due diligence, patentability analysis, patent term extension under 35 U.S.C. s. 156, and USPTO proceedings. He has extensive experience representing clients in the biotechnology and pharmaceutical industries. Specific technologies he has worked in include: pharmaceutical API (including polymorphs, solvates, and prodrugs) and API process and formulation; stem cells; gene therapy; enzymes; biological receptors; small peptides; and photodynamic therapy.
Dr. Frank also has in-depth experience in litigation support, particularly in working with experts in the relevant technological field.
Dr. Frank’s extensive post-undergraduate research experience includes investigations into transcriptional regulation and programmed cell death during early development.